December 02, 2020
Assaf Halevy, founder and CEO, 2bPrecise, and Jacob Johnson, MD, president, San Francisco Otolaryngology Medical Group, explain how pharmacogenomics help physicians prescribe patients the correct medications at the right time, what this means for health systems, and the benefits of implementing precision medicine at point of care.
About the speakers
Dr. Jacob Johnson serves as president of San Francisco Otolaryngology Medical Group and has been with the practice since he started as an otolaryngologist, head and neck surgeon in 2001. Dr. Johnson is a board certified physician and specializes in pediatric, sinus, ear, and thyroid patients.
Assaf Halevy is the founder and CEO of 2bPrecise, LLC, leading an international team dedicated to bridging the final mile between the science of genomics and making that data useful at the point of care.